These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30109979)

  • 1. Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease.
    Skinner D; Marro BS; Lane TE
    Viral Immunol; 2019; 32(1):25-37. PubMed ID: 30109979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination.
    Stiles LN; Liu MT; Kane JA; Lane TE
    Autoimmunity; 2009 Sep; 42(6):484-91. PubMed ID: 19626487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS.
    Stiles LN; Hosking MP; Edwards RA; Strieter RM; Lane TE
    Eur J Immunol; 2006 Mar; 36(3):613-22. PubMed ID: 16479546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection.
    Stiles LN; Hardison JL; Schaumburg CS; Whitman LM; Lane TE
    J Immunol; 2006 Dec; 177(12):8372-80. PubMed ID: 17142734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease.
    Liu MT; Chen BP; Oertel P; Buchmeier MJ; Armstrong D; Hamilton TA; Lane TE
    J Immunol; 2000 Sep; 165(5):2327-30. PubMed ID: 10946253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin F attenuates neuroinflammation and demyelination following murine coronavirus infection of the central nervous system.
    Syage AR; Pachow C; Murray KM; Henningfield C; Fernandez K; Du A; Cheng Y; Olivarria G; Kawauchi S; MacGregor GR; Green KN; Lane TE
    J Neuroinflammation; 2024 Jun; 21(1):157. PubMed ID: 38879499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis.
    Liu MT; Keirstead HS; Lane TE
    J Immunol; 2001 Oct; 167(7):4091-7. PubMed ID: 11564831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
    Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
    J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells.
    Trifilo MJ; Montalto-Morrison C; Stiles LN; Hurst KR; Hardison JL; Manning JE; Masters PS; Lane TE
    J Virol; 2004 Jan; 78(2):585-94. PubMed ID: 14694090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking.
    Dufour JH; Dziejman M; Liu MT; Leung JH; Lane TE; Luster AD
    J Immunol; 2002 Apr; 168(7):3195-204. PubMed ID: 11907072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM.
    Templeton SP; Perlman S
    Immunol Res; 2007; 39(1-3):160-72. PubMed ID: 17917063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine receptor CXCR2 and coronavirus-induced neurologic disease.
    Weinger JG; Marro BS; Hosking MP; Lane TE
    Virology; 2013 Jan; 435(1):110-7. PubMed ID: 23217621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection.
    Trifilo MJ; Bergmann CC; Kuziel WA; Lane TE
    J Virol; 2003 Apr; 77(7):4004-14. PubMed ID: 12634360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells.
    Bergmann CC; Parra B; Hinton DR; Ramakrishna C; Dowdell KC; Stohlman SA
    J Virol; 2004 Feb; 78(4):1739-50. PubMed ID: 14747539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination.
    González JM; Bergmann CC; Ramakrishna C; Hinton DR; Atkinson R; Hoskin J; Macklin WB; Stohlman SA
    Am J Pathol; 2006 Mar; 168(3):796-804. PubMed ID: 16507895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible Expression of CXCL1 within the Central Nervous System Amplifies Viral-Induced Demyelination.
    Marro BS; Grist JJ; Lane TE
    J Immunol; 2016 Feb; 196(4):1855-64. PubMed ID: 26773148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease.
    Dickey LL; Worne CL; Glover JL; Lane TE; O'Connell RM
    J Neuroinflammation; 2016 Sep; 13(1):240. PubMed ID: 27604627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of CD8+ T cells and viral spread to demyelinating disease.
    Marten NW; Stohlman SA; Atkinson RD; Hinton DR; Fleming JO; Bergmann CC
    J Immunol; 2000 Apr; 164(8):4080-8. PubMed ID: 10754301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis.
    Glass WG; Hickey MJ; Hardison JL; Liu MT; Manning JE; Lane TE
    J Immunol; 2004 Apr; 172(7):4018-25. PubMed ID: 15034013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system.
    Ramos SJ; Hardison JL; Stiles LN; Lane TE; Walsh CM
    Autoimmunity; 2007 Feb; 40(1):54-65. PubMed ID: 17364498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.